Skip to menu Skip to content Skip to footer
Honorary Professor Josephine Forbes
Honorary Professor

Josephine Forbes

Email: 

Overview

Availability

Honorary Professor Josephine Forbes is:
Available for supervision

Qualifications

  • Bachelor, University of Melbourne
  • Doctor of Philosophy, University of Melbourne

Works

Search Professor Josephine Forbes’s works on UQ eSpace

259 works between 1995 and 2025

201 - 220 of 259 works

2006

Journal Article

A developmental nephron deficit in rats is associated with increased susceptibility to a secondary renal injury due to advanced glycation end-products

Zimanyi, M. A., Denton, K. M., Forbes, J. M., Thallas-Bonke, V., Thomas, M. C., Poon, F. and Black, M. J. (2006). A developmental nephron deficit in rats is associated with increased susceptibility to a secondary renal injury due to advanced glycation end-products. Diabetologia, 49 (4), 801-810. doi: 10.1007/s00125-006-0175-x

A developmental nephron deficit in rats is associated with increased susceptibility to a secondary renal injury due to advanced glycation end-products

2006

Journal Article

Erratum: Advanced glycation end product intervention reduce diabetes-accelerated atherosclerosis (Diabetes (2005) 53, (1813-1823))

Forbes, J. M., Yee, L. T.L., Thallas, V., Lassila, M., Candido, R., Jandeleit-Dahm, K. A., Thomas, M. C., Burns, W. C., Deemer, E. K., Thorpe, S. R., Cooper, M. E. and Allen, T. J. (2006). Erratum: Advanced glycation end product intervention reduce diabetes-accelerated atherosclerosis (Diabetes (2005) 53, (1813-1823)). Diabetes, 55 (3)

Erratum: Advanced glycation end product intervention reduce diabetes-accelerated atherosclerosis (Diabetes (2005) 53, (1813-1823))

2006

Journal Article

Novel therapeutics for diabetic micro- and macrovascular complications

Soro-Paavonen, A. and Forbes, J. M. (2006). Novel therapeutics for diabetic micro- and macrovascular complications. Current Medicinal Chemistry, 13 (15), 1777-1788. doi: 10.2174/092986706777452515

Novel therapeutics for diabetic micro- and macrovascular complications

2005

Conference Publication

Advanced glycation end products and diabetic nephropathy

Thomas, Merlin C., Forbes, Josephine M. and Cooper, Mark E. (2005). Advanced glycation end products and diabetic nephropathy. doi: 10.1097/01.mjt.0000178769.52610.69

Advanced glycation end products and diabetic nephropathy

2005

Journal Article

Interactions between renin angiotensin system and advanced glycation in the kidney

Thomas, Merlin C., Tikellis, Christos, Burns, Wendy M., Bialkowski, Katarzyna, Cao, Zemin, Coughlan, Melinda T., Jandeleit-Dahm, Karen, Cooper, Mark E. and Forbes, Josephine M. (2005). Interactions between renin angiotensin system and advanced glycation in the kidney. Journal of the American Society of Nephrology, 16 (10), 2976-2984. doi: 10.1681/ASN.2005010013

Interactions between renin angiotensin system and advanced glycation in the kidney

2005

Journal Article

Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects

Calkin, Anna C., Forbes, Josephine M., Smith, Craig M., Lassila, Markus, Cooper, Mark E., Jandeleit-Dahm, Karin A. and Allen, Terri J. (2005). Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects. Arteriosclerosis, Thrombosis, and Vascular Biology, 25 (9), 1903-1909. doi: 10.1161/01.ATV.0000177813.99577.6b

Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects

2005

Journal Article

Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy

Forbes, Josephine M., Thorpe, Suzanne R., Thallas-Bonke, Vicki, Pete, Josefa, Thomas, Merlin C., Deemer, Elizabeth R., Bassal, Sahar, El-Osta, Assam, Long, David M., Panagiotopoulos, Sianna, Jerums, George, Osicka, Tanya M. and Cooper, Mark E. (2005). Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy. Journal of the American Society of Nephrology, 16 (8), 2363-2372. doi: 10.1681/ASN.2005010062

Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy

2005

Journal Article

High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction

Kooptiwut, Suwattanee, Kebede, Melkam, Zraika, Sakeneh, Visinoni, Sherley, Aston-Mourney, Kathryn, Favaloro, Jenny, Tikellis, Chris, Thomas, Merlin C., Forbes, Josephine M., Cooper, Mark E., Dunlop, Marjorie, Proietto, Joseph and Andrikopoulos, Sofianos (2005). High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction. Journal of Molecular Endocrinology, 35 (1), 39-48. doi: 10.1677/jme.1.01720

High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction

2005

Journal Article

Agents in development for the treatment of diabetic nephropathy

Fukami, Kei, Cooper, Mark and Forbes, Josephine M. (2005). Agents in development for the treatment of diabetic nephropathy. Expert Opinion On Investigational Drugs, 14 (3), 279-294. doi: 10.1517/13543784.14.3.279

Agents in development for the treatment of diabetic nephropathy

2005

Conference Publication

Renal intra-mitochondrial glycation drives deficiencies in the activity of manganese superoxide dismutase and complex I of the mitochondrial respiratory chain in diabetes

Coughlan, MT, Thorburn, DR, Fukami, K, Laskowski, A, Thallas-Bonke, V, Long, DM, Brownlee, M, Cooper, ME and Forbes, JM (2005). Renal intra-mitochondrial glycation drives deficiencies in the activity of manganese superoxide dismutase and complex I of the mitochondrial respiratory chain in diabetes. 41st Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Athens Greece, Sep 10-15, 2005. SPRINGER.

Renal intra-mitochondrial glycation drives deficiencies in the activity of manganese superoxide dismutase and complex I of the mitochondrial respiratory chain in diabetes

2005

Journal Article

Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin system

Rizkalla, Bishoy, Forbes, Josephine M., Cao, Zemin, Boner, Geoffrey and Cooper, Mark E. (2005). Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin system. Journal of Hypertension, 23 (1), 153-164. doi: 10.1097/00004872-200501000-00026

Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin system

2005

Journal Article

Interactions between the renin angiotensin system and advanced glycation in diabetic nephropathy

Thomas, M. C., Forbes, J. M. and Cooper, M. E. (2005). Interactions between the renin angiotensin system and advanced glycation in diabetic nephropathy. Annals of the New York Academy of Sciences, 1043 (1), 927-927. doi: 10.1196/annals.1333.141

Interactions between the renin angiotensin system and advanced glycation in diabetic nephropathy

2005

Conference Publication

Do extracellular (circulating or dietary) advanced glycation end products mediate mitochondrial dysfunction in the kidney?

Forbes, JM, Coughlan, MT, Fukami, K, Laskowski, A, Thallas-Bonke, V, Dinh, D, Long, DM, Brownlee, M, Cooper, ME and Thorburn, DR (2005). Do extracellular (circulating or dietary) advanced glycation end products mediate mitochondrial dysfunction in the kidney?. 41st Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Athens Greece, Sep 10-15, 2005. SPRINGER.

Do extracellular (circulating or dietary) advanced glycation end products mediate mitochondrial dysfunction in the kidney?

2005

Conference Publication

Low-molecular weight advanced glycation end products: Markers of tissue AGE accumulation and more?

Thomas, Merlin C., Forbes, Josephine M., MacIsaac, Richard, Jerums, George and Cooper, Mark E. (2005). Low-molecular weight advanced glycation end products: Markers of tissue AGE accumulation and more?. New York Academy of Sciences. doi: 10.1196/annals.1333.073

Low-molecular weight advanced glycation end products: Markers of tissue AGE accumulation and more?

2005

Conference Publication

Can advanced glycation end product inhibitors modulate more than one pathway to enhance renoprotection in diabetes?

Coughlan, Melinda T., Cooper, Mark E. and Forbes, Josephine M. (2005). Can advanced glycation end product inhibitors modulate more than one pathway to enhance renoprotection in diabetes?. New York Academy of Sciences. doi: 10.1196/annals.1333.087

Can advanced glycation end product inhibitors modulate more than one pathway to enhance renoprotection in diabetes?

2005

Conference Publication

Direct anti-atherogenic properties of PPAR alpha and PPAR gamma agonists

Cooper, ME, Forbes, JM, Smith, CM, Lassila, M, Jandeleit-Dahm, KA, Allen, TJ and Calkin, AC (2005). Direct anti-atherogenic properties of PPAR alpha and PPAR gamma agonists. 41st Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Athens Greece, Sep 10-15, 2005. SPRINGER.

Direct anti-atherogenic properties of PPAR alpha and PPAR gamma agonists

2004

Journal Article

Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-α - dependent pathway

Thallas-Bonke, Vicki, Lindschau, Carsten, Rizkalla, Bishoy, Bach, Leon A., Boner, Geoffrey, Meier, Matthias, Haller, Hermann, Cooper, Mark E. and Forbes, Josephine M. (2004). Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-α - dependent pathway. Diabetes, 53 (11), 2921-2930. doi: 10.2337/diabetes.53.11.2921

Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-α - dependent pathway

2004

Journal Article

The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetes

Forbes, Josephine M., Thomas, Merlin C., Thorpe, Suzanne R., Alderson, Nathan L. and Cooper, Mark E. (2004). The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetes. Kidney International, Supplement, 66 (S92), S105-S107. doi: 10.1111/j.1523-1755.2004.09225.x

The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetes

2004

Journal Article

The role of advanced glycation in reduced organic cation transport associated with experimental diabetes

Thomas, Merlin C., Tikellis, Christos, Kantharidis, Phillip, Burns, Wendy C., Cooper, Mark E. and Forbes, Josephine M. (2004). The role of advanced glycation in reduced organic cation transport associated with experimental diabetes. Journal of Pharmacology and Experimental Therapeutics, 311 (2), 456-466. doi: 10.1124/jpet.104.070672

The role of advanced glycation in reduced organic cation transport associated with experimental diabetes

2004

Conference Publication

Inhibitors of advanced glycation end product accumulation ameliorate renal injury in the diabetic apoE knockout mouse

Jandeleit-Dahm, KAM, Lassila, M, Seah, KK, Allen, TJ, Thallas, V, Thomas, MC, Candido, R, Burns, WC, Forbes, JM, Calkin, AC and Cooper, ME (2004). Inhibitors of advanced glycation end product accumulation ameliorate renal injury in the diabetic apoE knockout mouse. 40th Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Munich Germany, Sep 05-09, 2004. SPRINGER.

Inhibitors of advanced glycation end product accumulation ameliorate renal injury in the diabetic apoE knockout mouse

Funding

Current funding

  • 2024 - 2026
    Understanding RAGE Expression and Function in Human T and Dendritic Cells to Refine the Use of RAGE Targeting Therapeutics for Type 1 Diabetes Prevention
    Juvenile Diabetes Research Foundation - International
    Open grant
  • 2022 - 2026
    Designing and translating novel therapies for diabetes and kidney disease
    NHMRC Investigator Grants
    Open grant

Past funding

  • 2021 - 2024
    Innovative delivery methods for the biologic soluble RAGE to prevent Type 1 Diabetes
    JDRF Pilot and Innovation Awards
    Open grant
  • 2019 - 2021
    RAGE as a novel therapeutic target for T1D
    Juvenile Diabetes Research Foundation - International
    Open grant
  • 2019
    Dissolution DNP Hyperpolariser
    UQ Research Facilities Infrastructure Grants
    Open grant
  • 2019 - 2021
    Preventing progression of diabetic kidney disease by targeting mitochondrial function
    NHMRC Project Grant
    Open grant
  • 2016 - 2017
    Genetic susceptibility to mitochondrial dysfunction as a risk factor for diabetic nephropathy (DiaComp - NIH subaward administered by Augusta University)
    Augusta University
    Open grant
  • 2016 - 2018
    Advanced Glycation in the development of T1D (Helmsley Charitable Trust - George Eisenbath nPOD award for team science) - Administered by the University of Miami
    University of Miami
    Open grant
  • 2016 - 2020
    Investigating pathways to alleviate the burden of diabetes and kidney disease
    NHMRC Research Fellowship
    Open grant
  • 2016
    Mitochondrial dysfunction as a mediator of diabetic kidney disease
    Diabetes Australia Research Program
    Open grant
  • 2015 - 2018
    Environmental Determinants of Islet Autoimmunity (ENDIA) (University of Adelaide led JDRF Australian Type 1 Diabetes Clinical Research Network (T1DCRN) RFA )
    University of Adelaide
    Open grant
  • 2015 - 2017
    Kidney energetics in the development of nephropathy in type 1 diabetes (DiaComp - NIH subaward administered by Augusta University)
    Augusta University
    Open grant
  • 2015
    Glucose transport in the diabetic kidney
    Diabetes Australia Research Trust
    Open grant
  • 2015 - 2019
    IL-22 as a Suppressor of Pancreatic Beta-Cell Stress and a Treatment for Diabetes
    NHMRC Project Grant
    Open grant
  • 2014 - 2016
    Urinary metabolic profiles as predictors of early diabetic nephropathy
    Kidney Health Australia
    Open grant
  • 2013 - 2014
    Identification of a novel target for the treatment of diabetic kidney disease
    NHMRC Project Grant
    Open grant
  • 2013 - 2014
    Modern food processing as a contributor to type 1 diabetes
    NHMRC Project Grant
    Open grant
  • 2013 - 2015
    NHMRC Research Fellowship (SRF A): Delineating the role of advanced glycation in diabetes and nephropathy
    NHMRC Research Fellowship
    Open grant

Supervision

Availability

Honorary Professor Josephine Forbes is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Honorary Professor Josephine Forbes's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au